- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00745628
Chinese Cohort Study of Coronary Heart Disease (CCS-CHD)
September 2, 2008 updated by: Ministry of Science and Technology of the People´s Republic of China
Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients
Construction of coronary heart disease cohort of more than 10000 patients in China.
Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.
Study Overview
Status
Unknown
Conditions
Detailed Description
More than 40 hospitals of 16 provinces will enroll patients for this study.
The study will include patients with diagnosed coronary heart disease.
Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that.
Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease.
Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire.
Physicians will also take a second test on secondary prevention of CHD at that time.
Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.
Study Type
Observational
Enrollment (Anticipated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tao Hong, MD
- Phone Number: 2229 86-10-66551122
- Email: dr_hongtao@163.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100034
- Recruiting
- Peking University First Hospital
-
Contact:
- Tao Hong
- Phone Number: 2229 86-10-66551122
- Email: dr_hongtao@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Diagnosed coronary heart disease
Description
Inclusion Criteria:
- Diagnosed coronary heart disease
- Confirmed by coronary angiography;
- Diagnosed myocardial infarction;
- Typical symptom of ischemic chest pain with positive stress test;
- Willing to sign an inform consent.
Exclusion Criteria
- Patients won't sign an inform consent or will not comply with the follow up.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tao Hong, MD, Peking University First Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2008
Primary Completion (Anticipated)
December 1, 2010
Study Completion (Anticipated)
December 1, 2010
Study Registration Dates
First Submitted
September 2, 2008
First Submitted That Met QC Criteria
September 2, 2008
First Posted (Estimate)
September 3, 2008
Study Record Updates
Last Update Posted (Estimate)
September 3, 2008
Last Update Submitted That Met QC Criteria
September 2, 2008
Last Verified
May 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006BAI01A02-08
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Heart Diseases
-
Peking University Third HospitalCompletedCoronary Microvascular Dysfunction | Obstructive Coronary Heart DiseaseChina
-
Centro de estudios en Cardiologia IntervencionistaCompletedCoronary Heart Disease | Coronary RestenosisArgentina
-
Deutsches Herzzentrum MuenchenCompletedCoronary Heart DiseaseGermany
-
National Heart Centre SingaporeUnknownCoronary Heart DiseaseSingapore
-
Ralf Degenhardt, PhDB. Braun Melsungen AGCompletedCoronary Heart DiseasesIndia
-
Chinese PLA General HospitalUnknownPercutaneous Coronary Intervention | CHD - Coronary Heart Disease | In-stent RestenosisChina
-
Boston Scientific CorporationCompletedCardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, CoronaryUnited States
-
Shenyang Northern HospitalNot yet recruitingCoronary Heart Disease (CHD)China
-
Johns Hopkins UniversityCanon Medical Systems, USARecruiting
-
MedImmune LLCCompletedStable Coronary Heart DiseaseUnited States